Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer

por van Vloten, Jacob P, Matuszewska, Kathy, Minow, Mark A A, Minott, Jessica A, Santry, Lisa A, Pereira, Madison, Stegelmeier, Ashley A, McAusland, Thomas M, Klafuric, Elaine M, Karimi, Khalil, Colasanti, Joseph, McFadden, D Grant, Petrik, James J, Bridle, Byram W, Wootton, Sarah K
Publicado 2022